Letter to Drusilla J. Hufford, Director, Global Programs Division, USEPA

Document ID: EPA-HQ-OAR-2006-0159-0028
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: November 01 2006, at 12:46 PM Eastern Standard Time
Date Posted: November 14 2006, at 12:00 AM Eastern Standard Time
Comment Start Date: November 3 2006, at 07:49 AM Eastern Standard Time
Comment Due Date: December 4 2006, at 11:59 PM Eastern Standard Time
Tracking Number: 801dc6a4
View Document:  View as format xml

View Comment

Cover letter received by EPA on October 23, 2006 (with CONFIDENTIAL attachments) submitted by Robert M. Sussman of Latham and Watkins LLP, council for Amphastar Pharmaceuticals, In.c and Armstrong Pharmaceuticals, Inc.

Attachments:

Letter to Drusilla J. Hufford, Director, Global Programs Division, USEPA

Title:
Letter to Drusilla J. Hufford, Director, Global Programs Division, USEPA

Abstract:
Cover letter received by EPA on October 23, 2006 (with CONFIDENTIAL attachments) submitted by Robert M. Sussman of Latham and Watkins LLP, council for Amphastar Pharmaceuticals, In.c and Armstrong Pharmaceuticals, Inc.

View Attachment: View as format pdf

Related Comments

    View All
Total: 21
Comment submitted by B. Sachau
Public Submission    Posted: 11/06/2006     ID: EPA-HQ-OAR-2006-0159-0025

Dec 04,2006 11:59 PM ET
Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
Public Submission    Posted: 11/09/2006     ID: EPA-HQ-OAR-2006-0159-0026

Dec 04,2006 11:59 PM ET
Letter to Drusilla J. Hufford, Director, Global Programs Division, USEPA
Public Submission    Posted: 11/14/2006     ID: EPA-HQ-OAR-2006-0159-0028

Dec 04,2006 11:59 PM ET
Comment submitted by Steven H. Bernhardt, Global Director, Regulatory Affairs, Honeywell Specialty Materials
Public Submission    Posted: 12/06/2006     ID: EPA-HQ-OAR-2006-0159-0030

Dec 04,2006 11:59 PM ET
Comment submitted by Peter A. Blenkinsop, International Pharmaceutical Aerosol Consortium (IPAC)
Public Submission    Posted: 12/06/2006     ID: EPA-HQ-OAR-2006-0159-0031

Dec 04,2006 11:59 PM ET